MU School of Medicine Professor Smita Saxena addresses
demystifying neurodegenerative patterns, from amyotrophic
lateral sclerosis (ALS) to dementia, with her PATHWAYS faculty talk.
NextGen Precision Health’s PATHWAYS symposium successfully debuted March 22, with nearly 200 researchers from across the Ë¿¹Ïapp attending.
Held at the State Historical Society of Missouri in Columbia, the inaugural event centered on developing new scientific partnerships within the system and with private industry to target solutions for major health challenges in Missouri and beyond.
At PATHWAYS, research faculty, postdoctoral researchers and graduate students from several disciplines discussed collaborations to lower research barriers and jump-start new projects.
Among other attendees, Mizzou, Ë¿¹ÏappKC, Missouri S&T and Ë¿¹ÏappSL were represented at PATHWAYS by 100 poster presenters and 10 faculty speakers:
- Brett Froeliger, Ph.D., University of Missouri-Columbia professor of psychiatry and director of the Cognitive Neuroscience Systems (CNS) advanced technology core facility
- John Grinstead, Ph.D., Siemens Healthineers medical physicist based at the NextGen Precision Health building
- Michael Nichols, Ph.D., University of Missouri-St. Louis professor of chemistry & biochemistry and Director of the Ë¿¹ÏappSL Biochemistry & Biotechnology Program
- Robert Paul, Ph.D., University of Missouri-St. Louis professor of psychological sciences and Executive Director of the Missouri Institute of Mental Health
- Smita Saxena, Ph.D., University of Missouri-Columbia professor of physical medicine and rehabilitation, and NextGen principal investigator
- Julie Semon, Ph.D., Missouri University of Science and Technology associate professor of biological sciences
- Xing Song, Ph.D., University of Missouri-Columbia assistant professor of biomedical informatics, biostatistics and medical epidemiology
- John Spertus, M.D., University of Missouri-Kansas City professor of metabolic and vascular disease research and Director for the Departments of Biomedical and Health Informatics and Internal Medicine
- Maria Spletter, Ph.D., University of Missouri-Kansas City assistant professor of biological and biomedical systems
Next year, PATHWAYS will be held at the University of Missouri-Kansas City.
Highlighting the promise of personalized health care and the impact of large-scale interdisciplinary collaboration, the Ë¿¹Ïapp System’s NextGen Precision Health initiative is bringing together innovators from across the system’s four research universities, MU Health Care, MU Extension and industry partners in pursuit of life-changing precision health advancements. It’s a dynamic effort to leverage the strengths of the entire Ë¿¹Ïapp System toward a better future for Missouri’s health. The initiative is anchored at the , a state-of-the-art research facility expanding collaborations between researchers, clinicians and industry leaders.
Nearly 200 researchers from across the Ë¿¹Ïapp attended the inaugural NextGen Precision Health’s PATHWAYS symposium.
Dave Arnold, executive director of the NextGen Precision Health initiative, speaks at the PATHWAYS symposium.
MU School of Medicine Assistant Professor Xing Song delivers her PATHWAYS faculty talk about a better understanding of ALS.
NextGen Precision Health’s PATHWAYS symposium included keynote speaker Thomas Pedersen, CEO of NMD Pharma.
During his PATHWAYS faculty talk, MU Professor Brett Froeliger discusses translating addiction neuroscience research.
MU poster presenters at the PATHWAYS symposium included Ph.D. candidate Matthew Burke.
Reviewed 2024-09-19